Visualizaciones | |
---|---|
Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04) | 281 |
octubre 2023 | noviembre 2023 | diciembre 2023 | enero 2024 | febrero 2024 | marzo 2024 | abril 2024 | |
---|---|---|---|---|---|---|---|
Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04) | 1 | 2 | 9 | 4 | 2 | 6 | 2 |
Visualizaciones | |
---|---|
-Sirera - Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-....pdf | 6 |
Visualizaciones | |
---|---|
Estados Unidos | 172 |
Francia | 22 |
Alemania | 21 |
España | 20 |
China | 16 |
Vietnam | 6 |
Suecia | 5 |
Irlanda | 4 |
India | 3 |
Irán | 3 |
Visualizaciones | |
---|---|
Ashburn | 57 |
Alameda | 16 |
West Palm Beach | 14 |
Louisville | 13 |
Des Moines | 10 |
Lompoc | 8 |
San Mateo | 7 |
Valencia | 7 |
Boardman | 6 |
Hanoi | 6 |